XML 56 R31.htm IDEA: XBRL DOCUMENT v3.4.0.3
Segment Information (Tables)
9 Months Ended
Mar. 31, 2016
Segment Reporting Information [Line Items]  
Revenue by Reportable Segment
The following tables present revenue for each reportable segment and Corporate:
 
Three Months Ended March 31
(in millions)
2016
 
2015
Pharmaceutical
$
27,527

 
$
22,605

Medical
3,138

 
2,774

Total segment revenue
30,665

 
25,379

Corporate (1)
(3
)
 
(4
)
Total revenue
$
30,662

 
$
25,375


 
Nine Months Ended March 31
(in millions)
2016
 
2015
Pharmaceutical
$
80,954

 
$
66,440

Medical
9,220

 
8,540

Total segment revenue
90,174

 
74,980

Corporate (1)
(12
)
 
3

Total revenue
$
90,162

 
$
74,983


(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following tables present segment profit by reportable segment and Corporate:
 
Three Months Ended March 31
(in millions)
2016
 
2015
Pharmaceutical
$
660

 
$
567

Medical
128

 
102

Total segment profit
788

 
669

Corporate
(132
)
 
(78
)
Total operating earnings
$
656

 
$
591


 
Nine Months Ended March 31
(in millions)
2016
 
2015
Pharmaceutical
$
1,945

 
$
1,559

Medical
335

 
330

Total segment profit
2,280

 
1,889

Corporate
(441
)
 
(286
)
Total operating earnings
$
1,839

 
$
1,603

Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
March 31,
2016
 
June 30,
2015
Pharmaceutical
$
20,633

 
$
17,385

Medical
9,984

 
7,095

Corporate
3,438

 
5,662

Total assets
$
34,055

 
$
30,142